Pervasip Corp (PVSP)

[Debunkinator]

SEATTLE, WASHINGTON, July 06, 2022 (GLOBE NEWSWIRE) -- Pervasip Corp. (OTC: PVSP) (“Pervasip” or the “Company”), a developer of companies and technologies in high value emerging markets, today announced a partnership with KRTL Biotech to develop and launch a wellness joint venture.

Pervasip and KRTL Biotech collectively referred to as the “Parties”, building on years of development, combined with a network of world-renowned stakeholders in the wellness space, announce the development of the Artizen Wellness joint venture to bring high quality wellness and nutritional foods products to market. Using proprietary formulations targeting mood, mental health and various ailments, Artizen Wellness will use unique low-THC cannabinoids (CBD/CBG/other), terpenes and well-known plant extracts to develop a range of products for worldwide distribution.